0001560327-19-000027.txt : 20190215 0001560327-19-000027.hdr.sgml : 20190215 20190215160832 ACCESSION NUMBER: 0001560327-19-000027 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190213 FILED AS OF DATE: 20190215 DATE AS OF CHANGE: 20190215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thomas Corey E. CENTRAL INDEX KEY: 0001647486 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37496 FILM NUMBER: 19611585 MAIL ADDRESS: STREET 1: C/O RAPID7, INC. STREET 2: 100 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Rapid7, Inc. CENTRAL INDEX KEY: 0001560327 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 352423994 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 SUMMER STREET STREET 2: 13TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110-2131 BUSINESS PHONE: 617-247-1717 MAIL ADDRESS: STREET 1: 100 SUMMER STREET STREET 2: 13TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110-2131 FORMER COMPANY: FORMER CONFORMED NAME: Rapid7 Inc DATE OF NAME CHANGE: 20121015 4 1 wf-form4_155026489627813.xml FORM 4 X0306 4 2019-02-13 0 0001560327 Rapid7, Inc. RPD 0001647486 Thomas Corey E. C/O RAPID7, INC. 100 SUMMER STREET BOSTON MA 02110 1 1 0 0 President and CEO COMMON STOCK 2019-02-13 4 M 0 15000 2.17 A 503503 D COMMON STOCK 2019-02-13 4 S 0 11700 45.6733 D 491803 D COMMON STOCK 2019-02-13 4 S 0 3300 46.1874 D 488503 D COMMON STOCK 2019-02-13 4 S 0 8434 45.7637 D 141566 I By Trust COMMON STOCK 2019-02-13 4 S 0 1566 46.3656 D 140000 I By Trust Stock Option (Right to Buy) 2.17 2019-02-13 4 M 0 15000 0 D 2022-03-21 COMMON STOCK 15000.0 270366 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2018. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.07 to $46.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.07 to $46.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Corey E. Thomas Irrevocable Trust of 2016 on November 14, 2018. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.26 to $46.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Represents shares held by the Corey E. Thomas Irrevocable Trust of 2016, which is administrated by an independent trustee, and is for the benefit of the reporting person's immediate and other family members. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.27 to $46.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Immediately exercisable. /s/ Peter Kaes, Attorney-in-Fact 2019-02-15